Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

Share Price is delayed by 15 minutes
Get Live Data
14,318.00    256.00 (1.82%)
Bid:
14,256.00
Ask:
14,262.00
Spread: 6.00 (0.042%)
Market Cap: £222.05b
AZN Live PriceLast checked at - London Stock Exchange

Intraday Astrazeneca Share Chart

Astrazeneca News

US business lobby in China: Some pharma firms reporting tariff exemptions
25 Apr 2025

US business lobby in China: Some pharma firms reporting tariff exemptions

US business group says exemptions appear to be drug-specific *

China exempts some goods from US tariffs
25 Apr 2025

China exempts some goods from US tariffs

China exempts some U.S. imports from 125% tariffs *

AstraZeneca CEO says Europe must invest more to protect its 'health sovereignty'
23 Apr 2025

AstraZeneca CEO says Europe must invest more to protect its 'health sovereignty'

LONDON, April 23 (Reuters) - AstraZeneca Chief Executive Officer Pascal Soriot said on Wednesday that just like Europe has stepped up its defence sp...

European pharma companies push for higher drug prices in EU amid U.S. tariff threats
23 Apr 2025

European pharma companies push for higher drug prices in EU amid U.S. tariff threats

Sanofi, Novartis CEOs urge EU list price closer to US net levels *

AstraZeneca CEO says Europe must protect its health sovereignty, is falling behind on pharma investments
23 Apr 2025

AstraZeneca CEO says Europe must protect its health sovereignty, is falling behind on pharma investments

LONDON, April 23 (Reuters) - AstraZeneca Chief Executive Officer Pascal Soriot said on Wednesday that Europe has stepped up its defence spending and...

Hutchmed China completes enrolment for gastric cancer drug trial
22 Apr 2025

Hutchmed China completes enrolment for gastric cancer drug trial

(Alliance News) - Hutchmed China Ltd on Tuesday said it has completed patient enrolment for a phase II registration trial of savolitinib, targeting ga...

AstraZeneca receives positive Phase III trial results from Enhertu study
22 Apr 2025

AstraZeneca receives positive Phase III trial results from Enhertu study

(Sharecast News) - Drugmaker AstraZeneca said on Tuesday that it had received "positive high-level results" from a Phase III trial on its Enhertu cand...